HORMONE-REFRACTORY PROSTATE CANCER
Clinical trials for HORMONE-REFRACTORY PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new HORMONE-REFRACTORY PROSTATE CANCER trials appear
Sign up with your email to follow new studies for HORMONE-REFRACTORY PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene test could match prostate cancer patients to better chemo
Disease control OngoingThis study looks at whether men with advanced prostate cancer that no longer responds to hormone therapy have certain gene changes that make them more likely to benefit from a chemotherapy drug called carboplatin. Researchers will first screen participants for these gene changes,…
Matched conditions: HORMONE-REFRACTORY PROSTATE CANCER
Phase: PHASE2 • Sponsor: Institute of Cancer Research, United Kingdom • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
Prostate cancer drugs may cloud your mind: new study investigates
Knowledge-focused OngoingThis study looks at how certain hormone therapies for advanced prostate cancer might affect thinking skills like memory and attention. About 100 men who are already on these treatments will take thinking tests and have brain scans to see if there are changes. The goal is to under…
Matched conditions: HORMONE-REFRACTORY PROSTATE CANCER
Phase: PHASE4 • Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated May 17, 2026 04:36 UTC